Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.107 (
DAT
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Caenorhabditis elegans (
C. elegans)
dopamine (DA) transporter (
DAT
-1) regulates DA signaling through efficient DA reuptake following synaptic release. In addition to its DA transport function,
DAT
-1 generates detectable DA-gated currents that may influence neuronal excitability. Previously, we provided evidence that single Cl-channel events underlie
DAT
-1 currents. In these studies, we identified a distinct population of altered
DAT
-1 currents arising from
DAT
-1 transgenic constructs bearing an N-terminal GFP fusion. The presence of these channels suggested disruption of an endogenous regulatory mechanism that modulates occupancy of
DAT
-1 channel states. A leading candidate for such a regulator is the SNARE protein syntaxin 1A (Syn1A), previously found to interact with homologous transporters through N-terminal interactions. Here we establish that UNC-64 (C. elegans Syn1A homologue) associates with
DAT
-1 and suppresses transporter channel properties. In contrast, GFP::
DAT
-1 is unable to form stable transporter/UNC-64 complexes that limit channel states. Although
DAT
-1 and GFP::
DAT
-1 expressing DA neurons exhibit comparable DA uptake, GFP::
DAT
-1 animals exhibit swimming-induced paralysis (SWIP), a phenotype associated with excess synaptic DA release and spillover. We propose that loss of UNC-64/
DAT
-1 interactions leads to enhanced synaptic DA release, providing a novel mechanism for DA neuron sensitization that may be relevant to mechanisms of DA-associated disorders.
...
PMID:Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. 1876 15